$RWAY
Runway Growth Finance Corp

2023 Q1 Form 10-K Financial Statement

#000095017023005814 Filed on March 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $292.0K $36.81M $59.80M
YoY Change -98.48% 109.36% -16.2%
Cost Of Revenue $19.44M $15.67M $38.82M
YoY Change 306.96% 194.22% 86.87%
Gross Profit $19.87M $21.13M $69.73M
YoY Change 37.2% 72.48% 37.85%
Gross Profit Margin 6804.11% 57.42% 116.61%
Selling, General & Admin $1.442M $2.682M $9.157M
YoY Change -21.15% 283.78% 100.15%
% of Gross Profit 7.26% 12.69% 13.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $21.06M $2.774M $48.76M
YoY Change 941.95% 109.33% 700.31%
Operating Profit -$1.196M $18.36M $20.98M
YoY Change -109.6% 68.01% -52.86%
Interest Expense $10.92M $131.9K $16.76M
YoY Change -213.67% -98.43% 1387.02%
% of Operating Profit 0.72% 79.9%
Other Income/Expense, Net $180.0K $778.0K
YoY Change 36.36% 36.49%
Pretax Income $11.98M $18.49M $32.25M
YoY Change 320.04% -4.21% -29.31%
Income Tax $290.0K
% Of Pretax Income 0.9%
Net Earnings $11.98M $18.49M $32.25M
YoY Change 320.04% -4.21% -29.31%
Net Earnings / Revenue 4104.11% 50.24% 53.93%
Basic Earnings Per Share $0.30 $0.79
Diluted Earnings Per Share $0.30 $0.46 $0.79
COMMON SHARES
Basic Shares Outstanding 40.51M 40.52M 40.97M
Diluted Shares Outstanding 40.51M 40.97M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.271M $5.761M $5.761M
YoY Change -6.82% 22.66% 22.66%
Cash & Equivalents $3.271M $5.761M $5.761M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.271M $5.761M $5.761M
YoY Change -29.72% -10.86% -10.86%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.160B $1.126B $1.126B
YoY Change 53.83% 54.39% 54.39%
Other Assets
YoY Change
Total Long-Term Assets $1.170B $1.136B $1.136B
YoY Change 54.49% 55.22% 55.22%
TOTAL ASSETS
Total Short-Term Assets $3.271M $5.761M $5.761M
Total Long-Term Assets $1.170B $1.136B $1.136B
Total Assets $1.173B $1.142B $1.142B
YoY Change 53.98% 54.64% 54.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $10.15M $7.949M $7.949M
YoY Change 42.35% 3.66% 3.66%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.72M $16.76M $16.76M
YoY Change 169.23% -68.18% -68.18%
LONG-TERM LIABILITIES
Long-Term Debt $583.9M $549.0M $549.0M
YoY Change 278.87% 590.61% 590.61%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $583.9M $549.0M $549.0M
YoY Change 271.2% 590.61% 590.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.72M $16.76M $16.76M
Total Long-Term Liabilities $583.9M $549.0M $549.0M
Total Liabilities $603.6M $565.7M $565.7M
YoY Change 266.66% 328.08% 328.08%
SHAREHOLDERS EQUITY
Retained Earnings -$25.57M -$19.32M
YoY Change 7136.33%
Common Stock $606.2M $606.2M
YoY Change -0.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $569.8M $576.1M $576.1M
YoY Change
Total Liabilities & Shareholders Equity $1.173B $1.142B $1.142B
YoY Change 53.98% 54.64% 54.64%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $11.98M $18.49M $32.25M
YoY Change 320.04% -4.21% -29.31%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$18.53M -$195.7M -$359.8M
YoY Change -4.06% 195.64% 487.49%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $18.23M $51.59M
YoY Change 63.15% 187.46%
Common Stock Issuance & Retirement, Net $10.82M
YoY Change -90.93%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.04M 195.7M 360.9M
YoY Change -11.52% 179.73% 606.81%
NET CHANGE
Cash From Operating Activities -18.53M -195.7M -359.8M
Cash From Investing Activities
Cash From Financing Activities 16.04M 195.7M 360.9M
Net Change In Cash -2.490M -13.38K 1.064M
YoY Change 109.88% -100.36% -110.44%
FREE CASH FLOW
Cash From Operating Activities -$18.53M -$195.7M -$359.8M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001653384
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
814-01180
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5049745
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
205 N. Michigan Ave
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 4200
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60601
CY2022 dei City Area Code
CityAreaCode
312
CY2022 dei Local Phone Number
LocalPhoneNumber
698‑6902
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
false
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Entity Registrant Name
EntityRegistrantName
Runway Growth Finance Corp.
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
219000000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40509269
CY2022 dei Auditor Firm
AuditorFirmId
49
CY2022 dei Auditor Name
AuditorName
RSM US LLP
CY2022 dei Auditor Location
AuditorLocation
Chicago, Illinois
CY2022 cef Return At Minus Ten Percent
ReturnAtMinusTenPercent
-0.149
CY2022 cef Return At Minus Five Percent
ReturnAtMinusFivePercent
-0.050
CY2022 cef Return At Zero Percent
ReturnAtZeroPercent
0.049
CY2022 cef Return At Plus Five Percent
ReturnAtPlusFivePercent
0.148
CY2022 cef Return At Plus Ten Percent
ReturnAtPlusTenPercent
0.247
CY2023Q1 cef Latest Share Price
LatestSharePrice
12.89
CY2023Q1 cef Latest Premium Discount To Nav Percent
LatestPremiumDiscountToNavPercent
-0.094
CY2022 cef Latest Nav
LatestNav
14.22
CY2022Q4 cef Latest Nav
LatestNav
14.22
CY2022Q4 cef Highest Price Or Bid
HighestPriceOrBid
13.52
CY2022Q4 cef Lowest Price Or Bid
LowestPriceOrBid
11.31
CY2022Q4 cef Highest Price Or Bid Premium Discount To Nav Percent
HighestPriceOrBidPremiumDiscountToNavPercent
-0.049
CY2022Q4 cef Lowest Price Or Bid Premium Discount To Nav Percent
LowestPriceOrBidPremiumDiscountToNavPercent
-0.205
CY2022Q3 cef Latest Nav
LatestNav
14.12
CY2022Q3 cef Highest Price Or Bid
HighestPriceOrBid
13.81
CY2022Q3 cef Lowest Price Or Bid
LowestPriceOrBid
11.24
CY2022Q3 cef Highest Price Or Bid Premium Discount To Nav Percent
HighestPriceOrBidPremiumDiscountToNavPercent
-0.022
CY2022Q3 cef Lowest Price Or Bid Premium Discount To Nav Percent
LowestPriceOrBidPremiumDiscountToNavPercent
-0.204
CY2022Q2 cef Latest Nav
LatestNav
14.14
CY2022Q2 cef Highest Price Or Bid
HighestPriceOrBid
14.51
CY2022Q2 cef Lowest Price Or Bid
LowestPriceOrBid
10.98
CY2022Q2 cef Highest Price Or Bid Premium Discount To Nav Percent
HighestPriceOrBidPremiumDiscountToNavPercent
0.026
CY2022Q2 cef Lowest Price Or Bid Premium Discount To Nav Percent
LowestPriceOrBidPremiumDiscountToNavPercent
-0.223
CY2022Q1 cef Latest Nav
LatestNav
14.45
CY2022Q1 cef Highest Price Or Bid
HighestPriceOrBid
14.77
CY2022Q1 cef Lowest Price Or Bid
LowestPriceOrBid
12.21
CY2022Q1 cef Highest Price Or Bid Premium Discount To Nav Percent
HighestPriceOrBidPremiumDiscountToNavPercent
0.022
CY2022Q1 cef Lowest Price Or Bid Premium Discount To Nav Percent
LowestPriceOrBidPremiumDiscountToNavPercent
-0.155
CY2021Q4 cef Latest Nav
LatestNav
14.65
CY2021Q4 cef Highest Price Or Bid
HighestPriceOrBid
13.92
CY2021Q4 cef Lowest Price Or Bid
LowestPriceOrBid
12.04
CY2021Q4 cef Highest Price Or Bid Premium Discount To Nav Percent
HighestPriceOrBidPremiumDiscountToNavPercent
-0.050
CY2021Q4 cef Lowest Price Or Bid Premium Discount To Nav Percent
LowestPriceOrBidPremiumDiscountToNavPercent
-0.178
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1150602000
CY2021Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
727324000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1126309000
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
729516000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5761000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4697000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
6741000
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
2369000
CY2022Q4 us-gaap Other Assets
OtherAssets
2955000
CY2021Q4 us-gaap Other Assets
OtherAssets
1766000
CY2022Q4 us-gaap Assets
Assets
1141766000
CY2021Q4 us-gaap Assets
Assets
738348000
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
337000000
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
61000000
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
10293000
CY2021Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
1511000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
548957000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
79489000
CY2021Q4 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
44775000
CY2022Q4 us-gaap-supplement Incentive Fee Payable
IncentiveFeePayable
8808000
CY2021Q4 us-gaap-supplement Incentive Fee Payable
IncentiveFeePayable
6010000
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
6221000
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
249000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1728000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1630000
CY2022Q4 us-gaap Liabilities
Liabilities
565714000
CY2021Q4 us-gaap Liabilities
Liabilities
132153000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
414000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
414000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
605774000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
606048000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19320000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-267000
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
10816000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
576052000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
606195000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40509269
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41380614
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.22
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.65
CY2022 us-gaap Other Income
OtherIncome
2000
CY2021 us-gaap Other Income
OtherIncome
1000
CY2020 us-gaap Other Income
OtherIncome
50000
CY2022 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
108552000
CY2021 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
71358000
CY2020 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
57626000
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
11882000
CY2021 us-gaap Management Fee Expense
ManagementFeeExpense
8989000
CY2020 us-gaap Management Fee Expense
ManagementFeeExpense
6832000
CY2022 us-gaap Incentive Fee Expense
IncentiveFeeExpense
13183000
CY2021 us-gaap Incentive Fee Expense
IncentiveFeeExpense
9232000
CY2020 us-gaap Incentive Fee Expense
IncentiveFeeExpense
7261000
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
13756000
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
2554000
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
1064000
CY2022 us-gaap Professional Fees
ProfessionalFees
2815000
CY2021 us-gaap Professional Fees
ProfessionalFees
1844000
CY2020 us-gaap Professional Fees
ProfessionalFees
1597000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1020000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
827000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
678000
CY2022 us-gaap General Insurance Expense
GeneralInsuranceExpense
1016000
CY2021 us-gaap General Insurance Expense
GeneralInsuranceExpense
339000
CY2020 us-gaap General Insurance Expense
GeneralInsuranceExpense
105000
CY2022 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
658000
CY2021 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
579000
CY2020 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
516000
CY2022 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
3005000
CY2021 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
1638000
CY2020 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
736000
CY2022 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
352000
CY2021 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
293000
CY2020 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
248000
CY2022 us-gaap-supplement Investment Income Operating Tax Expense Benefit
InvestmentIncomeOperatingTaxExpenseBenefit
291000
CY2021 us-gaap-supplement Investment Income Operating Tax Expense Benefit
InvestmentIncomeOperatingTaxExpenseBenefit
1000
CY2020 us-gaap-supplement Investment Income Operating Tax Expense Benefit
InvestmentIncomeOperatingTaxExpenseBenefit
1000
CY2022 us-gaap Other Expenses
OtherExpenses
778000
CY2021 us-gaap Other Expenses
OtherExpenses
570000
CY2020 us-gaap Other Expenses
OtherExpenses
518000
CY2022 us-gaap Operating Expenses
OperatingExpenses
48756000
CY2020 us-gaap Net Investment Income
NetInvestmentIncome
38070000
CY2021 us-gaap Operating Expenses
OperatingExpenses
26866000
CY2020 us-gaap Operating Expenses
OperatingExpenses
19556000
CY2022 us-gaap Net Investment Income
NetInvestmentIncome
59796000
CY2021 us-gaap Net Investment Income
NetInvestmentIncome
44492000
CY2022 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-1061000
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
4172000
CY2020 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-5347000
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-26485000
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3045000
CY2020 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
14257000
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
-27546000
CY2021 us-gaap Gain Loss On Investments
GainLossOnInvestments
1127000
CY2020 us-gaap Gain Loss On Investments
GainLossOnInvestments
8910000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
32250000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
45619000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
46980000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.33
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.33
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.70
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.70
CY2022 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.46
CY2021 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.30
CY2020 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.38
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40971242
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40971242
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34183358
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34183358
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27617425
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27617425
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
376313000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
46980000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50316000
CY2020 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
32443000
CY2020 us-gaap Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts
-99000
CY2020 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
39709000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
466244000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
45619000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
119294000
CY2021 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
26995000
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts
-7014000
CY2021 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
44943000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
606195000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
32250000
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
10816000
CY2022 us-gaap Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts
16000
CY2022 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
51593000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
576052000
CY2022 us-gaap Profit Loss
ProfitLoss
32250000
CY2021 us-gaap Profit Loss
ProfitLoss
45619000
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
199000000
CY2020 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
162500000
CY2020 us-gaap Profit Loss
ProfitLoss
46980000
CY2022 us-gaap-supplement Payments For Purchase Of Investment Operating Activity
PaymentsForPurchaseOfInvestmentOperatingActivity
622719000
CY2021 us-gaap-supplement Payments For Purchase Of Investment Operating Activity
PaymentsForPurchaseOfInvestmentOperatingActivity
424445000
CY2020 us-gaap-supplement Payments For Purchase Of Investment Operating Activity
PaymentsForPurchaseOfInvestmentOperatingActivity
272533000
CY2022 us-gaap-supplement Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
8655000
CY2021 us-gaap-supplement Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
2992000
CY2020 us-gaap-supplement Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
3690000
CY2022 us-gaap-supplement Proceeds From Disposition Of Investment Operating Activity
ProceedsFromDispositionOfInvestmentOperatingActivity
168898000
CY2021 us-gaap-supplement Proceeds From Disposition Of Investment Operating Activity
ProceedsFromDispositionOfInvestmentOperatingActivity
303602000
CY2020 us-gaap-supplement Proceeds From Disposition Of Investment Operating Activity
ProceedsFromDispositionOfInvestmentOperatingActivity
110560000
CY2020 rway Proceeds From Sold Short
ProceedsFromSoldShort
26000000
CY2022 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-1061000
CY2021 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
4172000
CY2020 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-5347000
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-26485000
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3045000
CY2020 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
14257000
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
6863000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
7742000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
9256000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1390000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
472000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
225000
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
4372000
CY2021 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-314000
CY2020 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
741000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1189000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1270000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-73000
CY2022 us-gaap-supplement Increase Decrease In Incentive Fee Payable
IncreaseDecreaseInIncentiveFeePayable
2798000
CY2021 us-gaap-supplement Increase Decrease In Incentive Fee Payable
IncreaseDecreaseInIncentiveFeePayable
1003000
CY2020 us-gaap-supplement Increase Decrease In Incentive Fee Payable
IncreaseDecreaseInIncentiveFeePayable
1424000
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
5972000
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-219000
CY2020 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-32000
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
98000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
542000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-175000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-359846000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-61246000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-106091000
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
10172000
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
400000
CY2020 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
830000
CY2022 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
484000000
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
161000000
CY2021 rway Proceeds From Reverse Repurchase Agreements
ProceedsFromReverseRepurchaseAgreements
149249000
CY2020 rway Proceeds From Reverse Repurchase Agreements
ProceedsFromReverseRepurchaseAgreements
248749000
CY2022 rway Repayments Of Reverse Repurchase Agreements
RepaymentsOfReverseRepurchaseAgreements
44775000
CY2021 rway Repayments Of Reverse Repurchase Agreements
RepaymentsOfReverseRepurchaseAgreements
174124000
CY2020 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
200500000
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
208000000
CY2020 rway Repayments Of Reverse Repurchase Agreements
RepaymentsOfReverseRepurchaseAgreements
253693000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
10816000
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
51593000
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
17948000
CY2020 us-gaap Payments Of Dividends
PaymentsOfDividends
7266000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
-16000
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
7014000
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
99000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
119294000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50316000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
360910000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
51057000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
75177000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1064000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10189000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-30914000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4697000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14886000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45800000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5761000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4697000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14886000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
100000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
7784000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
2773000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
1096000
CY2022 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
6081000
CY2021 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
2925000
CY2020 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
23959000
CY2021 rway Non Cash Dividend Reinvestments
NonCashDividendReinvestments
26995000
CY2020 rway Non Cash Dividend Reinvestments
NonCashDividendReinvestments
32443000
CY2022Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.9552
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1150602000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1126309000
CY2022Q4 rway Percentage Of Net Assets At Fair Value Restricted To Resale
PercentageOfNetAssetsAtFairValueRestrictedToResale
0.0197
CY2021Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.2034
CY2021Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
727324000
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
729516000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:3.333%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of income and expense during the reporting period. Actual results could differ from those estimates.</span></p>
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
781498
CY2022 rway Market Value Of Collateral At Least Equal To Repurchase Price In Case Of Reverse Repurchase Agreement Percentage
MarketValueOfCollateralAtLeastEqualToRepurchasePriceInCaseOfReverseRepurchaseAgreementPercentage
1
CY2022 rway Market Value Of Collateral At Least Equal To Repurchase Price In Case Of Other Reverse Repurchase Agreements Percentage
MarketValueOfCollateralAtLeastEqualToRepurchasePriceInCaseOfOtherReverseRepurchaseAgreementsPercentage
1.02
CY2022Q4 us-gaap Securities For Reverse Repurchase Agreements
SecuritiesForReverseRepurchaseAgreements
0
CY2021Q4 us-gaap Assets Sold Under Agreements To Repurchase Market Value
AssetsSoldUnderAgreementsToRepurchaseMarketValue
45000000.0
CY2021Q4 us-gaap Assets Sold Under Agreements To Repurchase Repurchase Liability
AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability
44800000
CY2022 rway Percentage Of Net Assets On Non Cash Paid In Kind Interest
PercentageOfNetAssetsOnNonCashPaidInKindInterest
0.080
CY2021 rway Percentage Of Net Assets On Non Cash Paid In Kind Interest
PercentageOfNetAssetsOnNonCashPaidInKindInterest
0.042
CY2020 rway Percentage Of Net Assets On Non Cash Paid In Kind Interest
PercentageOfNetAssetsOnNonCashPaidInKindInterest
0.064
CY2021Q4 us-gaap Debt Securities Held To Maturity Nonaccrual
DebtSecuritiesHeldToMaturityNonaccrual
30300000
CY2021Q4 rway Debt Securities Held To Maturity Fair Value Non Accrual
DebtSecuritiesHeldToMaturityFairValueNonAccrual
28300000
CY2020Q4 rway Debt Securities Held To Maturity Percentage Of Net Assets Nonaccrual
DebtSecuritiesHeldToMaturityPercentageOfNetAssetsNonaccrual
0.039
CY2021 us-gaap Debt Securities Held To Maturity Nonaccrual Interest Income
DebtSecuritiesHeldToMaturityNonaccrualInterestIncome
4800000
CY2022 rway Percentage Of Minimum Beneficial Ownership Of Voting Securities For Control
PercentageOfMinimumBeneficialOwnershipOfVotingSecuritiesForControl
0.250
CY2022 rway Percentage Of Beneficial Ownership Of Voting Securities
PercentageOfBeneficialOwnershipOfVotingSecurities
0.050
CY2022 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
10900000
CY2021 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
1830974
CY2021 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
27000000.0
CY2020 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
4816873
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
70800000
CY2022 rway Percentage Of Taxable Income Paid Excise Tax
PercentageOfTaxableIncomePaidExciseTax
0.04
CY2022 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2021 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2020 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000
CY2022Q4 us-gaap Investment Company Financial Commitment To Investee Future Amount
InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount
315700000
CY2022Q4 us-gaap Investment Company Financial Commitment To Investee Future Amount
InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount
315685000
CY2021Q4 us-gaap Investment Company Financial Commitment To Investee Future Amount
InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount
187000000.0
CY2021Q4 us-gaap Investment Company Financial Commitment To Investee Future Amount
InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount
186985000
CY2022 rway Cash Flows Related To Unfunded Commitments And Determined Fair Value
CashFlowsRelatedToUnfundedCommitmentsAndDeterminedFairValue
0
CY2021 rway Cash Flows Related To Unfunded Commitments And Determined Fair Value
CashFlowsRelatedToUnfundedCommitmentsAndDeterminedFairValue
0
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000.0
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
871345
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10800000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
32250000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
45619000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
46980000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40971242
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34183358
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27617425
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40971242
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34183358
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27617425
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.33
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.70
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.33
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.70
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
871345
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10800000
CY2022 us-gaap Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2023-02-24
CY2022Q4 us-gaap Investment Company Distributable Earnings
InvestmentCompanyDistributableEarnings
-19320000
CY2022 rway Percentage Of Minimum Net Ordinary Income And Net Short Term Capital Gains In Excess Of Net Long Term Capital Losses For Distribution
PercentageOfMinimumNetOrdinaryIncomeAndNetShortTermCapitalGainsInExcessOfNetLongTermCapitalLossesForDistribution
0.90
CY2022 rway Percentage Of Taxable Income Paid Excise Tax
PercentageOfTaxableIncomePaidExciseTax
0.04
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
290000.0
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1300
CY2021 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
0
CY2021 rway Adjustments To Accumulated Undistributed Earnings Losses Dividends In Excess Of Retained Earnings
AdjustmentsToAccumulatedUndistributedEarningsLossesDividendsInExcessOfRetainedEarnings
0
CY2022 us-gaap-supplement Investment Company Distribution Ordinary Income
InvestmentCompanyDistributionOrdinaryIncome
51593000
CY2021 us-gaap-supplement Investment Company Distribution Ordinary Income
InvestmentCompanyDistributionOrdinaryIncome
44943000
CY2020 us-gaap-supplement Investment Company Distribution Ordinary Income
InvestmentCompanyDistributionOrdinaryIncome
39518000
CY2020 us-gaap-supplement Investment Company Distribution Long Term Capital Gain
InvestmentCompanyDistributionLongTermCapitalGain
191000
CY2022Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss
InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss
10473000
CY2021Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss
InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss
329000
CY2020Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss
InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss
1322000
CY2022Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward
InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward
-6011000
CY2021Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward
InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward
-2931000
CY2020Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward
InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward
-4359000
CY2022Q4 rway Investment Company Distributable Earnings Loss Other Accumulated Gain Loss
InvestmentCompanyDistributableEarningsLossOtherAccumulatedGainLoss
-189000
CY2021Q4 rway Investment Company Distributable Earnings Loss Other Accumulated Gain Loss
InvestmentCompanyDistributableEarningsLossOtherAccumulatedGainLoss
-213000
CY2020Q4 rway Investment Company Distributable Earnings Loss Other Accumulated Gain Loss
InvestmentCompanyDistributableEarningsLossOtherAccumulatedGainLoss
-236000
CY2022Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-23593000
CY2021Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
2548000
CY2020Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
2330000
CY2021Q4 us-gaap Investment Company Distributable Earnings
InvestmentCompanyDistributableEarnings
-267000
CY2020Q4 us-gaap Investment Company Distributable Earnings
InvestmentCompanyDistributableEarnings
-943000
CY2022 rway Percentage Of Minimum Net Ordinary Income For Each Calendar For Distribution
PercentageOfMinimumNetOrdinaryIncomeForEachCalendarForDistribution
0.98
CY2022 rway Percentage Of Minimum Capital Gains Exceed Capital Losses For Distribution For One Year Period
PercentageOfMinimumCapitalGainsExceedCapitalLossesForDistributionForOneYearPeriod
0.982
CY2022 rway Percentage Of Minimum Distribution Amount Exceeds Distributions For Year
PercentageOfMinimumDistributionAmountExceedsDistributionsForYear
0.04
CY2022 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
700000
CY2021 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
600000
CY2020 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
500000
CY2022 us-gaap-supplement Realized Gain Loss Investment And Derivative Operating Before Tax
RealizedGainLossInvestmentAndDerivativeOperatingBeforeTax
-900000
CY2022 us-gaap-supplement Unrealized Gain Loss Investment And Derivative Operating Before Tax
UnrealizedGainLossInvestmentAndDerivativeOperatingBeforeTax
-2200000
CY2021 us-gaap-supplement Realized Gain Loss Investment And Derivative Operating Before Tax
RealizedGainLossInvestmentAndDerivativeOperatingBeforeTax
-800000
CY2021 us-gaap-supplement Unrealized Gain Loss Investment And Derivative Operating Before Tax
UnrealizedGainLossInvestmentAndDerivativeOperatingBeforeTax
2800000
CY2020 us-gaap-supplement Realized Gain Loss Investment And Derivative Operating Before Tax
RealizedGainLossInvestmentAndDerivativeOperatingBeforeTax
1200000
CY2020 us-gaap-supplement Unrealized Gain Loss Investment And Derivative Operating Before Tax
UnrealizedGainLossInvestmentAndDerivativeOperatingBeforeTax
14200000
CY2022 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
13755000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1390000
CY2022 rway Unused Fees And Other Debt Fees
UnusedFeesAndOtherDebtFees
1615000
CY2022 us-gaap Interest Expense
InterestExpense
16759000
CY2021 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2544000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
472000
CY2021 rway Unused Fees And Other Debt Fees
UnusedFeesAndOtherDebtFees
1126000
CY2021 us-gaap Interest Expense
InterestExpense
4142000
CY2020 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
987000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
225000
CY2020 rway Unused Fees And Other Debt Fees
UnusedFeesAndOtherDebtFees
510000
CY2020 us-gaap Interest Expense
InterestExpense
1722000
CY2017Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
0
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
559250000
CY2022 rway Asset Coverage Per Unit
AssetCoveragePerUnit
2030000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
81000000
CY2021 rway Asset Coverage Per Unit
AssetCoveragePerUnit
8484000
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
99000000
CY2020 rway Asset Coverage Per Unit
AssetCoveragePerUnit
5710000
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
61000000
CY2019 rway Asset Coverage Per Unit
AssetCoveragePerUnit
7169000
CY2018Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
59500000
CY2018 rway Asset Coverage Per Unit
AssetCoveragePerUnit
3813000
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.65
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.84
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.58
CY2018Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
15.14
CY2017Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.66
CY2016Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
10.38
CY2015Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
15.00
CY2022 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.46
CY2021 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.30
CY2020 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.38
CY2019 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.95
CY2018 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.26
CY2017 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.66
CY2016 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-83.81
CY2016 rway Investment Company Issuance Of Common Shares
InvestmentCompanyIssuanceOfCommonShares
79.20
CY2022 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
1.26
CY2021 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
1.31
CY2020 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
1.44
CY2019 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
2.17
CY2018 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.77
CY2021 rway Investment Company Offering Costs Per Share
InvestmentCompanyOfferingCostsPerShare
-0.21
CY2019 rway Investment Company Offering Costs Per Share
InvestmentCompanyOfferingCostsPerShare
-0.03
CY2022 rway Investment Company Accretion Dilution Per Share
InvestmentCompanyAccretionDilutionPerShare
0.04
CY2020 rway Investment Company Accretion Dilution Per Share
InvestmentCompanyAccretionDilutionPerShare
-0.01
CY2019 rway Investment Company Accretion Dilution Per Share
InvestmentCompanyAccretionDilutionPerShare
0.16
CY2018 rway Investment Company Accretion Dilution Per Share
InvestmentCompanyAccretionDilutionPerShare
-0.01
CY2017 rway Investment Company Accretion Dilution Per Share
InvestmentCompanyAccretionDilutionPerShare
4.80
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.22
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.65
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.84
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.58
CY2018Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
15.14
CY2017Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.66
CY2016Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
10.38
CY2022 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0294
CY2021 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0128
CY2020 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0179
CY2019 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0370
CY2018 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0327
CY2017 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.4123
CY2016 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.3080
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40971242
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34183358
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27617425
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18701021
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9300960
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2795274
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10774
CY2022Q4 us-gaap Assets Net
AssetsNet
576052
CY2021Q4 us-gaap Assets Net
AssetsNet
606195
CY2020Q4 us-gaap Assets Net
AssetsNet
466244
CY2019Q4 us-gaap Assets Net
AssetsNet
376313
CY2018Q4 us-gaap Assets Net
AssetsNet
167369
CY2017Q4 us-gaap Assets Net
AssetsNet
127040
CY2016Q4 us-gaap Assets Net
AssetsNet
3477
CY2022 rway Average Net Assets
AverageNetAssets
589669
CY2021 rway Average Net Assets
AverageNetAssets
508836
CY2020 rway Average Net Assets
AverageNetAssets
403188
CY2019 rway Average Net Assets
AverageNetAssets
283774
CY2018 rway Average Net Assets
AverageNetAssets
141046
CY2017 rway Average Net Assets
AverageNetAssets
40389
CY2016 rway Average Net Assets
AverageNetAssets
152
CY2022 us-gaap Investment Company Expense Ratio Including Incentive Fee
InvestmentCompanyExpenseRatioIncludingIncentiveFee
0.0827
CY2021 us-gaap Investment Company Expense Ratio Including Incentive Fee
InvestmentCompanyExpenseRatioIncludingIncentiveFee
0.0528
CY2020 us-gaap Investment Company Expense Ratio Including Incentive Fee
InvestmentCompanyExpenseRatioIncludingIncentiveFee
0.0484
CY2019 us-gaap Investment Company Expense Ratio Including Incentive Fee
InvestmentCompanyExpenseRatioIncludingIncentiveFee
0.0658
CY2018 us-gaap Investment Company Expense Ratio Including Incentive Fee
InvestmentCompanyExpenseRatioIncludingIncentiveFee
0.0642
CY2017 us-gaap Investment Company Expense Ratio Including Incentive Fee
InvestmentCompanyExpenseRatioIncludingIncentiveFee
0.1246
CY2016 us-gaap Investment Company Expense Ratio Including Incentive Fee
InvestmentCompanyExpenseRatioIncludingIncentiveFee
5.9590
CY2022 rway Investment Company Ration Of Net Increase Decrease In Net Assets Resulting From Operations To Average Net Assets
InvestmentCompanyRationOfNetIncreaseDecreaseInNetAssetsResultingFromOperationsToAverageNetAssets
0.0547
CY2021 rway Investment Company Ration Of Net Increase Decrease In Net Assets Resulting From Operations To Average Net Assets
InvestmentCompanyRationOfNetIncreaseDecreaseInNetAssetsResultingFromOperationsToAverageNetAssets
0.0897
CY2020 rway Investment Company Ration Of Net Increase Decrease In Net Assets Resulting From Operations To Average Net Assets
InvestmentCompanyRationOfNetIncreaseDecreaseInNetAssetsResultingFromOperationsToAverageNetAssets
0.1162
CY2019 rway Investment Company Ration Of Net Increase Decrease In Net Assets Resulting From Operations To Average Net Assets
InvestmentCompanyRationOfNetIncreaseDecreaseInNetAssetsResultingFromOperationsToAverageNetAssets
0.0974
CY2018 rway Investment Company Ration Of Net Increase Decrease In Net Assets Resulting From Operations To Average Net Assets
InvestmentCompanyRationOfNetIncreaseDecreaseInNetAssetsResultingFromOperationsToAverageNetAssets
0.0834
CY2017 rway Investment Company Ration Of Net Increase Decrease In Net Assets Resulting From Operations To Average Net Assets
InvestmentCompanyRationOfNetIncreaseDecreaseInNetAssetsResultingFromOperationsToAverageNetAssets
-0.0356
CY2016 rway Investment Company Ration Of Net Increase Decrease In Net Assets Resulting From Operations To Average Net Assets
InvestmentCompanyRationOfNetIncreaseDecreaseInNetAssetsResultingFromOperationsToAverageNetAssets
-5.9590
CY2022 rway Investment Company Portfolio Turnover Rate
InvestmentCompanyPortfolioTurnoverRate
0.2006
CY2021 rway Investment Company Portfolio Turnover Rate
InvestmentCompanyPortfolioTurnoverRate
0.4961
CY2020 rway Investment Company Portfolio Turnover Rate
InvestmentCompanyPortfolioTurnoverRate
0.2514
CY2019 rway Investment Company Portfolio Turnover Rate
InvestmentCompanyPortfolioTurnoverRate
0.3299
CY2018 rway Investment Company Portfolio Turnover Rate
InvestmentCompanyPortfolioTurnoverRate
0.1166
CY2017 rway Investment Company Portfolio Turnover Rate
InvestmentCompanyPortfolioTurnoverRate
2.2709
CY2022 rway Investment Company Return From Investment Operations
InvestmentCompanyReturnFromInvestmentOperations
0.0997
CY2021 rway Investment Company Return From Investment Operations
InvestmentCompanyReturnFromInvestmentOperations
0.0876
CY2020 rway Investment Company Return From Investment Operations
InvestmentCompanyReturnFromInvestmentOperations
0.0947
CY2019 rway Investment Company Return From Investment Operations
InvestmentCompanyReturnFromInvestmentOperations
0.1288
CY2018 rway Investment Company Return From Investment Operations
InvestmentCompanyReturnFromInvestmentOperations
0.0859
CY2017 rway Investment Company Return From Investment Operations
InvestmentCompanyReturnFromInvestmentOperations
-0.0636
CY2016 rway Investment Company Return From Investment Operations
InvestmentCompanyReturnFromInvestmentOperations
-0.3080
CY2022 rway Investment Company Returns From Accretion Dilution
InvestmentCompanyReturnsFromAccretionDilution
0.0027
CY2021 rway Investment Company Returns From Accretion Dilution
InvestmentCompanyReturnsFromAccretionDilution
0.0000
CY2020 rway Investment Company Returns From Accretion Dilution
InvestmentCompanyReturnsFromAccretionDilution
-0.0006
CY2019 rway Investment Company Returns From Accretion Dilution
InvestmentCompanyReturnsFromAccretionDilution
0.0088
CY2018 rway Investment Company Returns From Accretion Dilution
InvestmentCompanyReturnsFromAccretionDilution
-0.0007
CY2017 rway Investment Company Returns From Accretion Dilution
InvestmentCompanyReturnsFromAccretionDilution
0.4624
CY2016 rway Investment Company Returns From Accretion Dilution
InvestmentCompanyReturnsFromAccretionDilution
0.0000
CY2022 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.1014
CY2021 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0874
CY2020 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0947
CY2019 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.1288
CY2018 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0830
CY2017 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
-0.0456
CY2016 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
-5.9590
CY2022 us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.0603
CY2021 us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.0347
CY2020 us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.0304
CY2019 us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.0364
CY2018 us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.0542
CY2017 us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.1246
CY2016 us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
5.9595
CY2022 cef Management Fees Percent
ManagementFeesPercent
0.0206
CY2022 cef Incentive Fees Percent
IncentiveFeesPercent
0.0229
CY2022 cef Interest Expenses On Borrowings Percent
InterestExpensesOnBorrowingsPercent
0.0239
CY2022 cef Other Annual Expenses Percent
OtherAnnualExpensesPercent
0.0018
CY2022 cef Total Annual Expenses Percent
TotalAnnualExpensesPercent
0.0692
CY2022 cef Expense Example Year01
ExpenseExampleYear01
73
CY2022 cef Expense Example Years1to3
ExpenseExampleYears1to3
213
CY2022 cef Expense Example Years1to5
ExpenseExampleYears1to5
347
CY2022 cef Expense Example Years1to10
ExpenseExampleYears1to10
657

Files In Submission

Name View Source Status
0000950170-23-005814-index-headers.html Edgar Link pending
0000950170-23-005814-index.html Edgar Link pending
0000950170-23-005814.txt Edgar Link pending
0000950170-23-005814-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img144853197_0.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rway-20221231.htm Edgar Link pending
rway-20221231.xsd Edgar Link pending
rway-ex23_1.htm Edgar Link pending
rway-ex31_1.htm Edgar Link pending
rway-ex31_2.htm Edgar Link pending
rway-ex32_1.htm Edgar Link pending
rway-ex32_2.htm Edgar Link pending
Show.js Edgar Link pending
rway-20221231_cal.xml Edgar Link unprocessable
rway-20221231_def.xml Edgar Link unprocessable
rway-20221231_pre.xml Edgar Link unprocessable
rway-20221231_lab.xml Edgar Link unprocessable
rway-20221231_htm.xml Edgar Link completed